Cargando…

Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art

Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are...

Descripción completa

Detalles Bibliográficos
Autores principales: Páez-Carpio, Alfredo, Gómez, Fernando M., Isus Olivé, Gemma, Paredes, Pilar, Baetens, Tarik, Carrero, Enrique, Sánchez, Marcelo, Vollmer, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085189/
https://www.ncbi.nlm.nih.gov/pubmed/33914187
http://dx.doi.org/10.1186/s13244-021-00997-5
_version_ 1783686281605152768
author Páez-Carpio, Alfredo
Gómez, Fernando M.
Isus Olivé, Gemma
Paredes, Pilar
Baetens, Tarik
Carrero, Enrique
Sánchez, Marcelo
Vollmer, Ivan
author_facet Páez-Carpio, Alfredo
Gómez, Fernando M.
Isus Olivé, Gemma
Paredes, Pilar
Baetens, Tarik
Carrero, Enrique
Sánchez, Marcelo
Vollmer, Ivan
author_sort Páez-Carpio, Alfredo
collection PubMed
description Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are no sufficiently representative studies to determine significant differences between the results of these techniques. However, a common feature among them is their excellent tolerance with very few complications. For optimal treatment, radiologists must carefully select the patients to be treated, perform a refined ablative technique, and have a detailed knowledge of the radiological features following lung ablation. Although no randomized studies comparing image-guided percutaneous lung ablation with surgery or stereotactic radiation therapy are available, the current literature demonstrates equivalent survival rates. This review will discuss image-guided percutaneous lung ablation features, including available modalities, approved indications, possible complications, published results, and future applications.
format Online
Article
Text
id pubmed-8085189
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80851892021-05-05 Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art Páez-Carpio, Alfredo Gómez, Fernando M. Isus Olivé, Gemma Paredes, Pilar Baetens, Tarik Carrero, Enrique Sánchez, Marcelo Vollmer, Ivan Insights Imaging Educational Review Image-guided percutaneous lung ablation has proven to be a valid treatment alternative in patients with early-stage non-small cell lung carcinoma or oligometastatic lung disease. Available ablative modalities include radiofrequency ablation, microwave ablation, and cryoablation. Currently, there are no sufficiently representative studies to determine significant differences between the results of these techniques. However, a common feature among them is their excellent tolerance with very few complications. For optimal treatment, radiologists must carefully select the patients to be treated, perform a refined ablative technique, and have a detailed knowledge of the radiological features following lung ablation. Although no randomized studies comparing image-guided percutaneous lung ablation with surgery or stereotactic radiation therapy are available, the current literature demonstrates equivalent survival rates. This review will discuss image-guided percutaneous lung ablation features, including available modalities, approved indications, possible complications, published results, and future applications. Springer International Publishing 2021-04-29 /pmc/articles/PMC8085189/ /pubmed/33914187 http://dx.doi.org/10.1186/s13244-021-00997-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Educational Review
Páez-Carpio, Alfredo
Gómez, Fernando M.
Isus Olivé, Gemma
Paredes, Pilar
Baetens, Tarik
Carrero, Enrique
Sánchez, Marcelo
Vollmer, Ivan
Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art
title Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art
title_full Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art
title_fullStr Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art
title_full_unstemmed Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art
title_short Image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art
title_sort image-guided percutaneous ablation for the treatment of lung malignancies: current state of the art
topic Educational Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085189/
https://www.ncbi.nlm.nih.gov/pubmed/33914187
http://dx.doi.org/10.1186/s13244-021-00997-5
work_keys_str_mv AT paezcarpioalfredo imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart
AT gomezfernandom imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart
AT isusolivegemma imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart
AT paredespilar imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart
AT baetenstarik imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart
AT carreroenrique imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart
AT sanchezmarcelo imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart
AT vollmerivan imageguidedpercutaneousablationforthetreatmentoflungmalignanciescurrentstateoftheart